Soligenix posts Phase 2 psoriasis trial results
The topical Hypericin study covered mild-to-moderate plaque psoriasis, adding a public registry marker for Soligenix’s dermatology pipeline.

Soligenix completed a Phase 2 clinical trial of topical Hypericin for mild-to-moderate plaque psoriasis, with results posted on ClinicalTrials.gov on Nov. 17, the clinical registry showed.
The posting matters because Phase 2 trials test whether a treatment merits larger studies; this record gives researchers and clinicians a public source to review for the psoriasis program.
The trial is listed under the record title “Topical SGX302 for Mild-to-Moderate Psoriasis” and carries the ClinicalTrials.gov identifier NCT05442190. The source identifies the condition as mild-to-moderate plaque psoriasis and the intervention as topical Hypericin.
The available information does not establish whether topical Hypericin improved plaque psoriasis or how it compared with another treatment or placebo.
For readers, the main point is procedural rather than clinical: a completed Phase 2 psoriasis trial now has results available for professional review. Any assessment of benefit or risk depends on the detailed registry results and later peer-reviewed or regulatory materials, if released.
Source: clinical registry, ClinicalTrials.gov, Nov. 17, 2026.
Atlas360 reports health research and does not provide medical advice.
More stories
- Dietitians advise small swaps for plant-based eating
- TikTok dementia videos mislead in 66.4% of sample, researchers say
- Aberdeen Royal Infirmary faces police inquiry call over 19 deaths
- Bariatric surgery group loses 28.2% after GLP-1 use
- TOFA boosts mouse energy use 18% while preserving muscle
- ICO probes NHS therapy notes accessible to up to 140,000 staff
- Europe faces 35,000 drug-resistance deaths a year
- U.S. faces loss of measles elimination status after 5,412 cases
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Europe faces attribution gap after 16 cyber, physical incidents

